Camedda N, Dagoli S, Anzillotti L, Cecchi R
Anal Sci Adv. 2025; 6(1):e202400038.
PMID: 39902462
PMC: 11789766.
DOI: 10.1002/ansa.202400038.
Fu Q, Han N, Li N, Gui L, Shi C, Rong P
Drug Des Devel Ther. 2024; 18:233-255.
PMID: 38362136
PMC: 10869233.
DOI: 10.2147/DDDT.S414318.
Villegas F, Martinez-Borba V, Suso-Ribera C, Castilla D, Zaragoza I, Garcia-Palacios A
Int J Environ Res Public Health. 2021; 18(11).
PMID: 34204871
PMC: 8199778.
DOI: 10.3390/ijerph18115991.
Wirz S, Schenk M, Hofbauer H, Wartenberg H, Cascella M, Kieselbach K
Schmerz. 2020; 35(2):114-123.
PMID: 32975670
DOI: 10.1007/s00482-020-00503-8.
Pieper L, Wager J, Zernikow B
BMC Palliat Care. 2018; 17(1):106.
PMID: 30200942
PMC: 6131941.
DOI: 10.1186/s12904-018-0361-x.
Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.
Kuip E, Oldenmenger W, Thijs-Visser M, de Bruijn P, Oosten A, Oomen-de Hoop E
PLoS One. 2018; 13(6):e0198289.
PMID: 29883454
PMC: 5993275.
DOI: 10.1371/journal.pone.0198289.
Prevalence and Characterization of Breakthrough Pain Associated with Chronic Low Back Pain in the South of Spain: A Cross-Sectional, Multicenter, Observational Study.
Torres L, Jimenez A, Cabezon A, Rodriguez M
Pain Res Treat. 2018; 2018:4325271.
PMID: 29850241
PMC: 5937435.
DOI: 10.1155/2018/4325271.
Characteristics and Treatment of Breakthrought Pain (BTcP) in Palliative Care.
Husic S, Imamovic S, Matic S, Sukalo A
Med Arch. 2017; 71(4):246-250.
PMID: 28974843
PMC: 5585809.
DOI: 10.5455/medarh.2017.71.246-250.
Fentanyl Inhibits Tumorigenesis from Human Breast Stem Cells by Inducing Apoptosis.
Kocak N, Ozen F, Yildirim I, Duran Y
Asian Pac J Cancer Prev. 2017; 18(3):735-739.
PMID: 28441707
PMC: 5464492.
DOI: 10.22034/APJCP.2017.18.3.735.
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.
Kuip E, Zandvliet M, Koolen S, Mathijssen R, van der Rijt C
Br J Clin Pharmacol. 2016; 83(2):294-313.
PMID: 27619152
PMC: 5237702.
DOI: 10.1111/bcp.13129.
Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
Minkowitz H, Bull J, Brownlow R, Parikh N, Rauck R
Support Care Cancer. 2016; 24(6):2669-75.
PMID: 26780504
DOI: 10.1007/s00520-015-3056-3.
A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.
Baek S, Kim D, Kang S, Sym S, Kim Y, Lee J
Cancer Res Treat. 2015; 48(2):768-74.
PMID: 26511815
PMC: 4843738.
DOI: 10.4143/crt.2015.087.
Nasal delivery of fentanyl.
Watts P, Smith A, Perelman M
Drug Deliv Transl Res. 2015; 3(1):75-83.
PMID: 25787867
DOI: 10.1007/s13346-012-0078-y.
Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin.
Zhang X, Chen M, Zhou S
Int J Clin Exp Pathol. 2015; 8(1):227-35.
PMID: 25755709
PMC: 4348846.
Breakthrough cancer pain: a comparison of surveys with European and Canadian patients.
Bedard G, Davies A, McDonald R, Hawley P, Buchanan A, Popovic M
Support Care Cancer. 2014; 23(3):791-6.
PMID: 25193599
DOI: 10.1007/s00520-014-2426-6.
Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.
Vardanyan R, Hruby V
Future Med Chem. 2014; 6(4):385-412.
PMID: 24635521
PMC: 4137794.
DOI: 10.4155/fmc.13.215.
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results.
Fernandez-Fernandez C, Callado L, Giron R, Sanchez E, Erdozain A, Lopez-Moreno J
Drug Des Devel Ther. 2014; 8:263-77.
PMID: 24591816
PMC: 3934591.
DOI: 10.2147/DDDT.S55045.
Single-dose fentanyl sublingual spray for breakthrough cancer pain.
Taylor D
Clin Pharmacol. 2013; 5:131-41.
PMID: 23901300
PMC: 3726301.
DOI: 10.2147/CPAA.S26649.
Fentanyl for the treatment of tumor-related breakthrough pain.
Bornemann-Cimenti H, Wejbora M, Szilagyi I, Sandner-Kiesling A
Dtsch Arztebl Int. 2013; 110(16):271-7.
PMID: 23671467
PMC: 3648890.
DOI: 10.3238/arztebl.2013.0271.
A survey of Canadian cancer patients' perspectives on the characteristics and treatment of breakthrough pain.
Bedard G, Hawley P, Zhang L, Slaven M, Gagnon P, Bisland S
Support Care Cancer. 2013; 21(9):2557-63.
PMID: 23636647
DOI: 10.1007/s00520-013-1817-4.